Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Current Leases (2019 - 2025)

Pulmonx (LUNG) has disclosed Current Leases for 7 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Leases rose 71.34% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 71.34% increase, with the full-year FY2024 number at $778000.0, down 74.69% from a year prior.
  • Current Leases was $1.1 million for Q3 2025 at Pulmonx, up from $1.1 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $3.4 million in Q3 2023 to a low of $663000.0 in Q3 2024.
  • A 5-year average of $2.2 million and a median of $2.2 million in 2021 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: soared 80.91% in 2022, then crashed 80.7% in 2024.
  • Pulmonx's Current Leases stood at $2.2 million in 2021, then soared by 46.71% to $3.2 million in 2022, then decreased by 4.8% to $3.1 million in 2023, then crashed by 74.69% to $778000.0 in 2024, then surged by 46.02% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Current Leases are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.1 million (Q1 2025).